Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00149760 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 2
- Development phase
- 88
- Enrollment target
NCT00149760: Completed Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
NCT00149760 is a Phase 2 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 88 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00149760, a Phase 2 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 88 participants
- Enrollment target
Study Summary
This study will examine the long-term effect of cognitive-affective behavior therapy on the physical symptoms, functioning, and health care utilization of people with somatization disorder.
Interventions
- BEHAVIORAL Augmented Standard Medical Care
- BEHAVIORAL Cognitive-Affective Behavior Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2003-08 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
What the finished NCT00149760 record still lists
NCT00149760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 2 interventions - of which Augmented Standard Medical Care is the first listed.
NCT00149760 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00149760 about?
NCT00149760 is a clinical study titled "Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder". This study will examine the long-term effect of cognitive-affective behavior therapy on the physical symptoms, functioning, and health care utilization of people with somatization disorder.
What is the current status of trial NCT00149760?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2003-08. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00149760?
The interventions under investigation include: Augmented Standard Medical Care (BEHAVIORAL), Cognitive-Affective Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00149760?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00149760's enrollment target sits among peer trials
88 803rd of 2000 higher than 1,191 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia